Sep 2026· American Journal of Transplantation· 1 citation· 39 references
Medicine
TL;DR
A potential involvement of vascular remodelling in CLAD pathophysiology is suggested, with changes consistent with pro-inflammatory and fibrogenic processes in CD31+ regions.
Abstract
Chronic lung allograft dysfunction (CLAD) is the leading cause of late morbidity and mortality after lung transplantation. Bronchiolitis obliterans syndrome (BOS), a major CLAD phenotype, is characterized by obliterative bronchiolitis (OB). While microvascular perturbations are described in BOS, their cellular and molecular characteristics remain unclear. Intact human CLAD lungs (n=3) underwent hierarchical phase-contrast tomography (HiP-CT) for three-dimensional vascular mapping. In OB-affected airways vs. controls (n=4 each), endothelial subtypes were characterized by multiplex immunofluorescence imaging, interactome changes quantified with CellChat and GeoMx spatial transcriptomics performed on CD31+ regions. HiP-CT revealed hypertrophic vessels infiltrating obliterated airways and forming web-like microvascular networks, absent in controls. Immunofluorescent imaging showed increased PLVAP+/VWA1+ systemic venous and PDPN+ lymphatic cells in OB lesions. Cell-cell interaction analysis showed that PLVAP+/VWA1+ systemic venous cells exhibited increased incoming and outgoing interaction strength, primarily directed toward other endothelial cells and fibroblasts, characterized by inflammatory and fibrotic signalling. Spatial transcriptomics demonstrated upregulation of inflammatory/matrix-remodelling genes and downregulation of homeostatic regulators in BOS endothelial cells. BOS lungs display altered vascular architecture and endothelial composition, with gene expression shifts consistent with pro-inflammatory and fibrogenic processes in CD31+ regions. These findings suggest a potential involvement of vascular remodelling in CLAD pathophysiology.
BOS engages structural-cell circuits largely shared with RAS and fibrotic lung diseases, but along an airway-centered rather than parenchyma-centered axis, and shared structural programs may therefore be targetable across CLAD phenotypes.
Jannik Ruwisch, Hande Yilmaz, Leonard Christian et al.· bioRxiv· 0 citations
OBJECTIVES
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are rare, severe forms of pulmonary hypertension (PH) characterized by elevated mean pulmonary arterial pressure (mPAP) and ∼20% mortality at 3 years. PAH is defined by progressive obliterative vasculopathy, where...
M. Peracaula, Daniel Aguilar, Á. Vea et al.· Archivos de Bronconeumologia· 0 citations
Background:
Pulmonary hypertension (PH) is a progressive disorder characterized by vasoconstriction, in situ thrombosis, and remodeling of small pulmonary arteries, leading to increased pulmonary vascular resistance and right ventricular failure. Despite extensive research using diverse animal models, the pathogenesis...
Matilde Baltazares-Lipp, Claudia Hernández-Jiménez, Rogelio Jasso-Victoria et al.· Open Veterinary Journal· 0 citations
The concept that T cells in IPF adopt nonclassical activation patterns that are driven by epithelial interactions within the fibrotic microenvironment is supported.
A. Serezani, J. Bazzano, B. Pascoalino et al.· JCI Insight· 0 citations
Pulmonary vein stenosis (PVS) is a rare but life-threatening disease affecting young children, characterized by progressive narrowing of the pulmonary veins. Multimodal treatment, including surgical and catheter-based interventions combined with medical therapy, can improve survival; however, disease recurrence and pro...
M. E. Moss, T. Klouda· Children· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.